KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Interest Expenses (2016 - 2026)

Novartis Ag's Interest Expenses history spans 16 years, with the latest figure at -$343.0 million for Q1 2026.

  • On a quarterly basis, Interest Expenses fell 27.04% to -$343.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.2 billion, a 15.36% decrease, with the full-year FY2025 number at $1.1 billion, up 13.72% from a year prior.
  • Interest Expenses hit -$343.0 million in Q1 2026 for Novartis Ag, down from -$304.0 million in the prior quarter.
  • Over the last five years, Interest Expenses for NVS hit a ceiling of -$200.0 million in Q1 2023 and a floor of -$403.0 million in Q2 2022.
  • Historically, Interest Expenses has averaged -$256.8 million across 5 years, with a median of -$246.0 million in 2024.
  • Biggest five-year swings in Interest Expenses: skyrocketed 46.4% in 2023 and later decreased 27.04% in 2026.
  • Tracing NVS's Interest Expenses over 5 years: stood at -$207.0 million in 2022, then dropped by 4.83% to -$217.0 million in 2023, then fell by 26.73% to -$275.0 million in 2024, then fell by 10.55% to -$304.0 million in 2025, then fell by 12.83% to -$343.0 million in 2026.
  • Business Quant data shows Interest Expenses for NVS at -$343.0 million in Q1 2026, -$304.0 million in Q4 2025, and -$281.0 million in Q3 2025.